BDG
0.092
84%
MHK
0.175
-53.9%
OLI
0.009
80%
AQC
0.009
-40%
BSA
0.13
78.1%
GTN
0.365
-38.7%
PIM
0.065
62.5%
GMN
0.057
-37.4%
1AE
0.077
60.4%
XPN
0.008
-33.3%
HCT
0.11
50.7%
LM1
0.099
-31.7%
I88
0.17
41.7%
RPG
0.165
-31.3%
CYQ
0.004
33.3%
SS1
0.76
-29.6%
GTR
0.004
33.3%
SYR
0.27
-28%
IMI
0.012
33.3%
CDE
0.019
-26.9%
LKY
0.14
33.3%
DTM
0.003
-25%
PXX
0.012
33.3%
RGL
0.003
-25%
RMY
0.04
33.3%
ROG
0.003
-25%
CMB
0.425
32.8%
GGP
5.18
-24.8%
IAM
0.038
31%
CTT
0.275
-24.7%
BCA
0.345
30.2%
CGR
0.05
-23.1%
MGU
0.009
28.6%
3DP
0.047
-23%
4DX
0.305
27.1%
YRL
0.12
-22.6%
X2M
0.019
26.7%
ANR
0.007
-22.2%
ART
0.36
26.3%
PLC
0.007
-22.2%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Creating better tests to diagnose various neurodevelopmental conditions

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab’s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:

📱 BlinkLab’s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes

Watch the full interview ⚡️ https://www.youtube.com/watch?v=t7z7g9kUTvA
Register to attend Australian Equities Day: https://www.eventbrite.sg/e/spark-plus-australian-equities-day-tickets-939180011697

Write to us
  • © 2025 Copyright
  • The Stock Network
  • All rights reserved